Cargando…
Fragment Merging Using a Graph Database Samples Different Catalogue Space than Similarity Search
[Image: see text] Fragment merging is a promising approach to progressing fragments directly to on-scale potency: each designed compound incorporates the structural motifs of overlapping fragments in a way that ensures compounds recapitulate multiple high-quality interactions. Searching commercial c...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268959/ https://www.ncbi.nlm.nih.gov/pubmed/37229647 http://dx.doi.org/10.1021/acs.jcim.3c00276 |
_version_ | 1785059140989616128 |
---|---|
author | Wills, Stephanie Sanchez-Garcia, Ruben Dudgeon, Tim Roughley, Stephen D. Merritt, Andy Hubbard, Roderick E. Davidson, James von Delft, Frank Deane, Charlotte M. |
author_facet | Wills, Stephanie Sanchez-Garcia, Ruben Dudgeon, Tim Roughley, Stephen D. Merritt, Andy Hubbard, Roderick E. Davidson, James von Delft, Frank Deane, Charlotte M. |
author_sort | Wills, Stephanie |
collection | PubMed |
description | [Image: see text] Fragment merging is a promising approach to progressing fragments directly to on-scale potency: each designed compound incorporates the structural motifs of overlapping fragments in a way that ensures compounds recapitulate multiple high-quality interactions. Searching commercial catalogues provides one useful way to quickly and cheaply identify such merges and circumvents the challenge of synthetic accessibility, provided they can be readily identified. Here, we demonstrate that the Fragment Network, a graph database that provides a novel way to explore the chemical space surrounding fragment hits, is well-suited to this challenge. We use an iteration of the database containing >120 million catalogue compounds to find fragment merges for four crystallographic screening campaigns and contrast the results with a traditional fingerprint-based similarity search. The two approaches identify complementary sets of merges that recapitulate the observed fragment–protein interactions but lie in different regions of chemical space. We further show our methodology is an effective route to achieving on-scale potency by retrospective analyses for two different targets; in analyses of public COVID Moonshot and Mycobacterium tuberculosis EthR inhibitors, potential inhibitors with micromolar IC(50) values were identified. This work demonstrates the use of the Fragment Network to increase the yield of fragment merges beyond that of a classical catalogue search. |
format | Online Article Text |
id | pubmed-10268959 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-102689592023-06-16 Fragment Merging Using a Graph Database Samples Different Catalogue Space than Similarity Search Wills, Stephanie Sanchez-Garcia, Ruben Dudgeon, Tim Roughley, Stephen D. Merritt, Andy Hubbard, Roderick E. Davidson, James von Delft, Frank Deane, Charlotte M. J Chem Inf Model [Image: see text] Fragment merging is a promising approach to progressing fragments directly to on-scale potency: each designed compound incorporates the structural motifs of overlapping fragments in a way that ensures compounds recapitulate multiple high-quality interactions. Searching commercial catalogues provides one useful way to quickly and cheaply identify such merges and circumvents the challenge of synthetic accessibility, provided they can be readily identified. Here, we demonstrate that the Fragment Network, a graph database that provides a novel way to explore the chemical space surrounding fragment hits, is well-suited to this challenge. We use an iteration of the database containing >120 million catalogue compounds to find fragment merges for four crystallographic screening campaigns and contrast the results with a traditional fingerprint-based similarity search. The two approaches identify complementary sets of merges that recapitulate the observed fragment–protein interactions but lie in different regions of chemical space. We further show our methodology is an effective route to achieving on-scale potency by retrospective analyses for two different targets; in analyses of public COVID Moonshot and Mycobacterium tuberculosis EthR inhibitors, potential inhibitors with micromolar IC(50) values were identified. This work demonstrates the use of the Fragment Network to increase the yield of fragment merges beyond that of a classical catalogue search. American Chemical Society 2023-05-25 /pmc/articles/PMC10268959/ /pubmed/37229647 http://dx.doi.org/10.1021/acs.jcim.3c00276 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Wills, Stephanie Sanchez-Garcia, Ruben Dudgeon, Tim Roughley, Stephen D. Merritt, Andy Hubbard, Roderick E. Davidson, James von Delft, Frank Deane, Charlotte M. Fragment Merging Using a Graph Database Samples Different Catalogue Space than Similarity Search |
title | Fragment Merging
Using a Graph Database Samples Different
Catalogue Space than Similarity Search |
title_full | Fragment Merging
Using a Graph Database Samples Different
Catalogue Space than Similarity Search |
title_fullStr | Fragment Merging
Using a Graph Database Samples Different
Catalogue Space than Similarity Search |
title_full_unstemmed | Fragment Merging
Using a Graph Database Samples Different
Catalogue Space than Similarity Search |
title_short | Fragment Merging
Using a Graph Database Samples Different
Catalogue Space than Similarity Search |
title_sort | fragment merging
using a graph database samples different
catalogue space than similarity search |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268959/ https://www.ncbi.nlm.nih.gov/pubmed/37229647 http://dx.doi.org/10.1021/acs.jcim.3c00276 |
work_keys_str_mv | AT willsstephanie fragmentmergingusingagraphdatabasesamplesdifferentcataloguespacethansimilaritysearch AT sanchezgarciaruben fragmentmergingusingagraphdatabasesamplesdifferentcataloguespacethansimilaritysearch AT dudgeontim fragmentmergingusingagraphdatabasesamplesdifferentcataloguespacethansimilaritysearch AT roughleystephend fragmentmergingusingagraphdatabasesamplesdifferentcataloguespacethansimilaritysearch AT merrittandy fragmentmergingusingagraphdatabasesamplesdifferentcataloguespacethansimilaritysearch AT hubbardrodericke fragmentmergingusingagraphdatabasesamplesdifferentcataloguespacethansimilaritysearch AT davidsonjames fragmentmergingusingagraphdatabasesamplesdifferentcataloguespacethansimilaritysearch AT vondelftfrank fragmentmergingusingagraphdatabasesamplesdifferentcataloguespacethansimilaritysearch AT deanecharlottem fragmentmergingusingagraphdatabasesamplesdifferentcataloguespacethansimilaritysearch |